 |
* Requires
|
|
 |
FUTURE ONCOLOGY
Volume 8 #5 June 2005
MEETING COVERAGE
TARGETING FOR CANCER IMAGING AND THERAPY
FROM THE "IMMUNE, VASCULAR AND GENE TARGETING FOR CANCER IMAGING AND THERAPY" MEETING ORGANIZED BY THE SIDNEY KIMMEL CANCER CENTER
IN SAN DIEGO, CA. FEBRUARY 28-MARCH 2, 2005
DELIVERY OF DRUGS TO TUMORS
- Enhancing Dilivery of Drugs to Tumors
- Stem cells
- Multivalent monoclonal antibodies (MAb)
- Polymerized vesicles (PV)
- Pulsed high intensity focused ultrasound (HIFU)
- TC1 MAb
- Adoptive cell transfer (ACT)
- Gene transfer
THERAPEUTIC APPROACHES IN DEVELOPMENT
- Apoptosis Enhancing Approaches
- Oncogene Inactivation
- PSF protein and mouse VL30 (mVL30) retrotransposon RNA complexes
- Oligonucleotides against jun kinase (JNK)
- MDX-010
- Angiogenesis Inhibitors/Antimetastatic Agents
- Oncolytic Measles Virus
TECHNOLOGY ADVANCES
- Proteomics
- FLEXGene (Full Length EXpression-ready) repository
- Target Identification in Prostate Cancer
DIAGNOSIS, PROGNOSIS AND DISEASE MONITORING
- Molecular Portraits by Cancer Type
- Serum-based Approaches
- Tumor Hypoxia
- Stem Cells
- MALDI (Matrix Assisted Laser Desprption Ionization) Mass Spectrometry
MECHANISMS IN MALIGNANCY
THE c-Src SIGNAL TRANSDUCTION PATHWAY
THE Src KINASE FAMILY (SKF)
c-Src
- Bone Metabolism
- Regulation of Angiogenesis
- Promotion of Metastasis
MALIGNANCIES ASSOCIATED WITH c-Src
- Bone Cancer
- Breast Cancer
- Chronic Myelogenous Leukemia (CML)
- Colorectal Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
AGENTS IN DEVELOPMENT TARGETING THE c-Src PATHWAY
- AP22408, AP23236, AP23451
- AP23464
- AZD0530
- AZM475271 (M475271)
- BMS-354825
- GN963
- SKI-606
- Other Programs
LIST OF EXHIBITS
Exhibit 1 - Drugs in Development Targeting the Src Pathway
|
|
|
|
